Global Alpha Capital Management Ltd. Purchases 3,457 Shares of Balchem Co. (NASDAQ:BCPC)

Global Alpha Capital Management Ltd. boosted its stake in Balchem Co. (NASDAQ:BCPC - Free Report) by 25.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,109 shares of the basic materials company's stock after purchasing an additional 3,457 shares during the quarter. Global Alpha Capital Management Ltd. owned about 0.05% of Balchem worth $2,789,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. State Street Corp raised its position in shares of Balchem by 1.0% during the 3rd quarter. State Street Corp now owns 1,234,226 shares of the basic materials company's stock valued at $217,224,000 after buying an additional 12,006 shares in the last quarter. Geode Capital Management LLC raised its position in Balchem by 3.1% during the third quarter. Geode Capital Management LLC now owns 928,904 shares of the basic materials company's stock valued at $163,514,000 after purchasing an additional 27,979 shares in the last quarter. Geneva Capital Management LLC boosted its holdings in shares of Balchem by 5.1% in the 4th quarter. Geneva Capital Management LLC now owns 819,746 shares of the basic materials company's stock worth $133,615,000 after purchasing an additional 39,877 shares in the last quarter. FMR LLC increased its position in shares of Balchem by 944.3% during the 3rd quarter. FMR LLC now owns 497,495 shares of the basic materials company's stock valued at $87,559,000 after purchasing an additional 449,854 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in shares of Balchem by 1.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 458,986 shares of the basic materials company's stock valued at $80,782,000 after buying an additional 7,721 shares in the last quarter. 87.91% of the stock is currently owned by institutional investors.

Remove Ads

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. StockNews.com lowered Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th. Sidoti upgraded shares of Balchem to a "hold" rating in a research report on Tuesday, February 25th. Finally, HC Wainwright restated a "buy" rating and set a $190.00 price target on shares of Balchem in a research report on Monday, February 24th.

Balchem Trading Down 1.0 %

Shares of NASDAQ:BCPC traded down $1.72 during trading on Wednesday, reaching $167.48. 152,974 shares of the company traded hands, compared to its average volume of 140,504. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19. Balchem Co. has a 52-week low of $137.69 and a 52-week high of $186.03. The firm has a market capitalization of $5.45 billion, a price-to-earnings ratio of 42.62, a P/E/G ratio of 4.41 and a beta of 0.63. The business's fifty day moving average is $163.42 and its 200-day moving average is $169.84.

Balchem (NASDAQ:BCPC - Get Free Report) last announced its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share for the quarter, missing the consensus estimate of $1.11 by ($0.08). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The firm had revenue of $240.00 million for the quarter, compared to analysts' expectations of $239.96 million. As a group, analysts forecast that Balchem Co. will post 4.64 EPS for the current year.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.